As of 2026-02-02, the Relative Valuation of Axsome Therapeutics Inc (AXSM) is (88.94) USD. This relative valuation is based on P/E multiples. With the latest stock price at 184.25 USD, the upside of Axsome Therapeutics Inc based on Relative Valuation is -148.3%.
The range of the Relative Valuation is (86.18) - (92.10) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.9x - 20.5x | 19.5x |
| Forward P/E multiples | 18.9x - 20.2x | 19.6x |
| Fair Price | (86.18) - (92.10) | (88.94) |
| Upside | -146.8% - -150.0% | -148.3% |
| Date | P/E |
| 2026-01-30 | -40.45 |
| 2026-01-29 | -40.67 |
| 2026-01-28 | -40.65 |
| 2026-01-27 | -41.28 |
| 2026-01-26 | -40.51 |
| 2026-01-23 | -40.83 |
| 2026-01-22 | -41.05 |
| 2026-01-21 | -41.52 |
| 2026-01-20 | -40.51 |
| 2026-01-16 | -38.92 |
| 2026-01-15 | -38.23 |
| 2026-01-14 | -38.86 |
| 2026-01-13 | -38.27 |
| 2026-01-12 | -38.82 |
| 2026-01-09 | -37.19 |
| 2026-01-08 | -36.78 |
| 2026-01-07 | -37.47 |
| 2026-01-06 | -37.73 |
| 2026-01-05 | -37.65 |
| 2026-01-02 | -39.23 |
| 2025-12-31 | -40.10 |
| 2025-12-30 | -32.67 |
| 2025-12-29 | -33.08 |
| 2025-12-26 | -33.38 |
| 2025-12-24 | -33.73 |
| 2025-12-23 | -33.85 |
| 2025-12-22 | -33.96 |
| 2025-12-19 | -33.51 |
| 2025-12-18 | -32.27 |
| 2025-12-17 | -32.49 |
| 2025-12-16 | -32.24 |
| 2025-12-15 | -32.11 |
| 2025-12-12 | -32.53 |
| 2025-12-11 | -32.66 |
| 2025-12-10 | -32.77 |
| 2025-12-09 | -31.88 |
| 2025-12-08 | -32.40 |
| 2025-12-05 | -32.76 |
| 2025-12-04 | -32.50 |
| 2025-12-03 | -32.45 |
| 2025-12-02 | -31.19 |
| 2025-12-01 | -32.72 |
| 2025-11-28 | -33.26 |
| 2025-11-26 | -33.15 |
| 2025-11-25 | -33.01 |
| 2025-11-24 | -33.19 |
| 2025-11-21 | -32.81 |
| 2025-11-20 | -31.46 |
| 2025-11-19 | -32.22 |
| 2025-11-18 | -32.38 |